InsiderTrades

Form 4 for BFRI Biofrontera Inc.

Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-18 · accession 0001493152-24-021033 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-22 2024-05-18 BFRI Luebbert Hermann CEO, Exec. COB, Dir M - OptEx — +4,771 15.2K +46% —
D 2024-05-22 2024-05-18 BFRI Luebbert Hermann CEO, Exec. COB, Dir M - OptEx $0.00 -4,771 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-18 M A 4,771 — 15,211 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2024-05-18 M D 4,771 $0.00 0 D — · — to — 4,771 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On May 18, 2022, the reporting person was granted 9,542 restricted stock units, vesting in two equal annual installments beginning on May 18, 2023.